A review of research on pediatric screening for high blood pressure showed a lack of evidence that such screening could reduce the risk of suffering from cardiovascular disease in adulthood, leading the U.S. Preventive Services Task Force to call for greater emphasis on studying outcomes for childhood interventions. Seven studies revealed that drug intervention effectively lowered blood pressure levels among teens in the short term. The review was published in the journal Pediatrics, and the draft Recommendation Statement is open for comments until March 26.
USPSTF: Benefits of early screening for hypertension unclear
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan